Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2024. Start Trial.
Date Value
October 02, 2026 0.8925
October 01, 2026 0.8823
September 30, 2026 0.855
September 29, 2026 0.8721
September 28, 2026 0.8891
September 25, 2026 0.9061
September 24, 2026 0.8857
September 23, 2026 0.9198
September 22, 2026 0.9811
September 21, 2026 0.9641
September 18, 2026 0.9572
September 17, 2026 0.9538
September 16, 2026 0.9606
September 15, 2026 0.9572
September 14, 2026 0.9675
September 11, 2026 0.9641
September 10, 2026 0.9675
September 09, 2026 0.9709
September 08, 2026 0.9743
September 04, 2026 0.9777
September 03, 2026 0.9777
September 02, 2026 0.9845
September 01, 2026 0.9845
August 31, 2026 0.9572
August 28, 2026 0.9641
Date Value
August 27, 2026 0.9743
August 26, 2026 0.993
August 25, 2026 1.002
August 24, 2026 1.008
August 21, 2026 1.022
August 20, 2026 0.9879
August 19, 2026 0.9743
August 18, 2026 0.9743
August 17, 2026 0.9641
August 14, 2026 0.9641
August 13, 2026 0.9453
August 12, 2026 0.947
August 11, 2026 0.9368
August 10, 2026 0.9606
August 07, 2026 0.9845
August 06, 2026 0.9675
August 05, 2026 0.9538
August 04, 2026 0.9215
August 03, 2026 0.8755
July 31, 2026 0.8516
July 30, 2026 0.8516
July 29, 2026 0.8448
July 28, 2026 0.8414
July 27, 2026 0.8448
July 24, 2026 0.8755

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.591
Alnylam Pharmaceuticals, Inc. 21.42
Savara, Inc. 6.849
Vericel Corp. 5.587
Biogen, Inc. 1.717

Price to Book Value Related Metrics

Price 2.63
Earnings Yield -108.6%
Market Cap 59.11M